Huhtamäki Oyj
Huhtamaki publishes Q1 2025 Interim Report on April 24, 2025
Huhtamaki publishes Q1 2025 Interim Report on April 24, 2025
HUHTAMÄKI OYJ PRESS RELEASE 8.4.2025 AT 13:00 EEST
Huhtamaki publishes Q1 2025 Interim Report on April 24, 2025
Huhtamäki Oyj will publish its Q1 2025 Interim Report on Thursday, April 24, 2025 at approximately 8:30 (EEST). The release and related results presentation material will be available after publishing at www.huhtamaki.com/investors.
Huhtamaki will arrange a combined audiocast and teleconference on the same day at 9:00 (please note the exceptional time). Huhtamaki’s President & CEO Ralf K. Wunderlich and CFO Thomas Geust will present the results. The event will be followed by a Q&A session. The event will be held in English, and it can be followed in real-time.
A link to the audiocast is available at: https://huhtamaki.events.inderes.com/q1-2025
A link to the teleconference is available at: https://events.inderes.com/huhtamaki/q1-2025/dial-in.
Registration is required for the teleconference. After the registration you will be provided with phone numbers and a conference ID to access the conference.
An on-demand replay of the audiocast will be available shortly after the end of the call at www.huhtamaki.com/investors.
For further information, please contact:
Kristian Tammela, Vice President, Investor Relations, tel. +358 10 686 7058
HUHTAMÄKI OYJ
Corporate Communications
About Huhtamaki
Huhtamaki is a leading global provider of sustainable packaging solutions for consumers around the world. Our innovative products protect on-the-go and on-the-shelf food and beverages, and personal care products, ensuring hygiene and safety, driving accessibility and affordability, and helping prevent food waste. We embed sustainability in everything we do.
Huhtamaki has over 100 years of history and a strong Nordic heritage. Our around 18 000 professionals are operating in 36 countries and 101 locations around the world. Our values are Care Dare Deliver. In 2024 Huhtamaki’s net sales totaled EUR 4.1 billion. Huhtamäki Oyj is listed on the Nasdaq Helsinki and the head office is in Espoo, Finland. Find out more at www.huhtamaki.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV21.5.2025 07:30:00 CEST | Press release
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants
Jeito Capital21.5.2025 07:05:00 CEST | Press release
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health
Augustine Therapeutics21.5.2025 07:00:00 CEST | Press release
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
Idorsia Pharmaceuticals Ltd21.5.2025 07:00:00 CEST | Press release
New funds secured – allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia’s path to profitability
Orion Oyj21.5.2025 06:30:00 CEST | Press release
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom